Chinanews.com, April 2. According to foreign media reports, recently, a joint research team of the German Red Cross Blood Donation Department and the Institute of Medical Virology of the University of Frankfurt Hospital developed a method that significantly improved the efficiency of detecting the new crown virus. Without affecting the quality of the diagnosis.
Beginning at 00:00 on March 23, Berlin and the German states began to implement the strictest foot-bans since the outbreak of the new crown pneumonia epidemic. Among them, Berlin is the first time to adopt severe measures such as prohibiting the gathering of two or more people in public places and closing restaurant cafes . Photo by China Press Agency Peng Dawei
German Minister of Science Hessian Dorn announced in Mainz that this new test method will be immediately available worldwide. She informed that scientists have found a way to detect multiple samples simultaneously. In this way, the current average level of 40,000 tests per day in Germany can be raised to 200,000 to 400,000 per day, and "the quality of diagnosis is not affected."
It is reported that the leader of the joint research team is Professor Sevried of the German Red Cross and Professor Zezek of Frankfurt University Hospital.
Dorn pointed out that an important goal of the new crown pneumonia war is to improve detection capabilities. "Only in this way, we can identify infected people as soon as possible and isolate them to protect others."
She said, "This method developed by Frankfurt experts is an amazing invention, and it is optimistic to believe that more people will be tested in the future, especially in the fields of health care, rescue services and the food industry. People. "
She also pointed out that, in general, mucosal samples taken from the throat or nasal cavity of a person are tested separately, and in the new method, experts put multiple samples into a special solution at the same time, using the commonly known polymerase chain Detection of New Coronavirus by PCR-based reaction technology (PCR), the New Coronavirus gene contained in the sampling can be directly confirmed. Once the test result is negative, one can be confident that all of the samples were free of neocoronavirus.
In addition, the Hessian Ministry of Science stated in a notification that the invention has been patented in the United States and Europe, and is shared by the Goethe University in Frankfurt and the German Red Cross Blood Donation Department. The technology is transferred through the Goethe University knowledge transfer company Innovectis. Available immediately to other interested institutions.